Title: Tan L, et al. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors. Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):E4869-4877.
149506-34-3 | 2-(4-broMophenyl)propane-1,3-diol | AA00ABRU | MFCD06203011
149632-73-5 | tert-Butyl N-(1-aminopropan-2-yl)carbamate | AA00ABX0 | MFCD16660178
16053-39-7 | H-Phe-ser-oh | AA00ACGD | MFCD00083787
1960-52-7 | 2-Methyl-4-nitrobenzotrifluoride | AA00ACTI | MFCD11226539
19156-52-6 | 4,5-Dimethylthiophene-3-carboxylic acid | AA00ACZH | MFCD01859967
16337-02-3 | (3R,6R)-3,6-Bis[(aminooxy)methyl]-2,5-piperazinedione | AA00AD6I | MFCD16038770
168627-33-6 | N-Cyclopropylguanidine compound with sulfuric acid (2:1) | AA00ACYB | MFCD05022503
14382-79-7 | (3β,16E,20β)-16,17-Didehydro-9,17-dimethoxycorynan-16-carboxylic acid methyl ester | AA00ADJC
17614-10-7 | (1-Methylethyl)carbaMic Acid Phenyl Ester | AA00ADSH | MFCD00276276
15569-99-0 | 4-(METHYLAMINO)-4-(3-PYRIDYL)BUTYRIC ACID | AA00AE01 | MFCD03412512